CVE & CISA-KEV Catalog

CVE-2022-32741

MEDIUM
5.3
CVSS v3
NVD

Description

Attacker is able to determine if the provided username exists (and it's valid) using Request New Password feature, based on the response time.

How to fix

Remediation Available
otrsNVD
Affected:>= 8.0.0, < 8.0.23Fixed in:8.0.23CVE-2022-32741derived from NVD

Remediation is compiled from vendor and distribution security advisories. Always confirm against the linked source for your exact version and platform.

CVSS v3 Vector

Exploitability

Attack VectorNetwork
Attack ComplexityLow
Privileges RequiredNone
User InteractionNone
ScopeUnchanged

Impact

ConfidentialityLow
IntegrityNone
AvailabilityNone

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N

Exploit Intelligence

0.80%probability of exploitation in 30 days
52ndpercentile

Moderate risk: more likely to be exploited than 52% of all known CVEs.

References

Vendor Advisory1

Related Vulnerabilities

Other CWE-200 (Information Exposure) vulnerabilities, ordered by exploit likelihood. View all

CVESeverityCVSSEPSSExploitedFix
CVE-2024-24919High8.6100%KEV + Ransom-
CVE-2020-14181Medium5.3100%-Fix
CVE-2021-34429Medium5.399%-Fix
CVE-2018-11409Medium5.398%--
CVE-2021-41277Critical10.097%KEV-
CVE-2016-2183High7.596%-Fix
Embed a live status badge for CVE-2022-32741
CVE-2022-32741 severity badge

Markdown

[![CVE-2022-32741](https://tridentstack.com/cve/badge/CVE-2022-32741.svg)](https://tridentstack.com/cve/CVE-2022-32741)

HTML

<a href="https://tridentstack.com/cve/CVE-2022-32741"><img src="https://tridentstack.com/cve/badge/CVE-2022-32741.svg" alt="CVE-2022-32741"></a>

Find and fix vulnerabilities across your fleet

TridentStack Control continuously scans your Windows, macOS, and Linux fleet for known vulnerabilities, prioritizes them by severity and active exploitation, and patches them automatically.

Start free

This product uses NVD data but is not endorsed or certified by the NVD. EPSS scores courtesy of FIRST.org (https://www.first.org/epss). Source: CISA KEV Catalog. Data as of 2024-11-21.